Jun 27 |
Tenaya Therapeutics Announces Research Leadership Updates
|
Jun 18 |
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
|
Jun 10 |
William Blair starts Tenaya at outperform, cites upcoming data
|
May 25 |
We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate
|
May 15 |
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
|
May 15 |
Tenaya Therapeutics GAAP EPS of -$0.40 beats by $0.02
|
May 14 |
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 12 |
13 Penny Stocks with Insider Buying in 2024
|
May 2 |
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
|
Apr 14 |
Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company
|